Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid?

This publication has 17 references indexed in Scilit:

• Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2020
• National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
  Journal of Clinical Lipidology, 2019
• Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
  New England Journal of Medicine, 2019
• A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins
  Journal of Cardiology, 2017
• Internal tissue references for 18Fluorodeoxyglucose vascular inflammation imaging: Implications for cardiovascular risk stratification and clinical trials
  PLOS ONE, 2017
• Marine OMEGA-3 fatty acids in the prevention of cardiovascular disease
  Fitoterapia, 2017
• Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans
  Circulation, 2016
• A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease
  Clinical Nutrition, 2016
• Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis
  European Journal of Nuclear Medicine and Molecular Imaging, 2015
• Measurement of Arterial Activity on Routine FDG PET/CT Images Improves Prediction of Risk of Future CV Events
  JACC: Cardiovascular Imaging, 2013